[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fns2avn5836XOKIQ31d7GkxUKoEOcpDt12rwXmLIPWuw":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":7,"truncated":8,"activeTrials":9,"phase3Count":10,"totalEnrollment":11,"activePrograms":12,"nonDrugCount":13,"topConditions":14,"upcomingReadouts":35,"phaseBuckets":81,"rows":88},"Queen's University",[4,6],"Queen's University, Belfast",334,false,39,20,102980,12,256,[15,18,21,24,26,28,31,33],{"name":16,"count":17},"Depression",13,{"name":19,"count":20},"Obesity",8,{"name":22,"count":23},"Healthy",7,{"name":25,"count":23},"Chronic Obstructive Pulmonary Disease",{"name":27,"count":23},"Physical Activity",{"name":29,"count":30},"Hypertension",6,{"name":32,"count":30},"Dementia",{"name":34,"count":30},"Glaucoma",[36,41,46,51,56,61,66,71,76],{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT06402383","Supporting the National Expansion of HPV-based Cervical Cancer Screening in Tanzania Among Women Living with HIV","2026-01","Vaccination Provision",{"nctId":42,"briefTitle":43,"date":44,"intervention":45},"NCT06828484","Allergenic Extract Standardized Cat Hair AP in an Allergic Rhinitis Model.","2026-01-08","Allergenic Extract Standardized Cat Hair Acetone-Precipitated",{"nctId":47,"briefTitle":48,"date":49,"intervention":50},"NCT06218030","Adjunctive Treatment With L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Pilot Study","2026-04-01","L-methylfolate",{"nctId":52,"briefTitle":53,"date":54,"intervention":55},"NCT06969170","Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder","2026-06-01","Psilocybin",{"nctId":57,"briefTitle":58,"date":59,"intervention":60},"NCT06736158","Early Genomic Testing for Inherited Bleeding Disorders","2026-12-31","Genetic testing for inherited bleeding disorders",{"nctId":62,"briefTitle":63,"date":64,"intervention":65},"NCT07064863","A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC.","2027-07-31","Gemcitabine + BCG",{"nctId":67,"briefTitle":68,"date":69,"intervention":70},"NCT07030426","Vaginal Estrogen for Improvement of Outcomes Following Pelvic Organ Prolapse Surgery","2027-09-30","Vaginal Estrogen - Twice Weekly",{"nctId":72,"briefTitle":73,"date":74,"intervention":75},"NCT07456670","Caffeine for Infants Born at 28 to 34 Weeks Receiving Respiratory Support","2028-03-31","Caffeine",{"nctId":77,"briefTitle":78,"date":79,"intervention":80},"NCT07009158","Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD","2029-09","Ketamine",[82,83,84,85,86,87],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[89,114,138,156,178,203,221,242,292,314,338,356,377,445,468,504,540,574,599,625,643,670,688,706,729,753,778,801,819,844,869,894,920,943,967,991,1018,1036,1054,1081,1099,1117,1140,1165,1190,1208,1230,1248,1275,1300,1318,1336,1354,1380,1405,1423,1448,1466,1489,1513,1531,1553,1580,1605,1623,1649,1674,1692,1717,1735,1758,1781,1806,1832,1870,1900,1931,1954,1979,1997,2015,2038,2061,2086,2112,2130,2155,2173,2195,2217,2243,2267,2289,2307,2325,2350,2373,2391,2409],{"intervention":50,"totalTrials":90,"cells":91},1,{"EARLY_PHASE1":92,"PHASE1":95,"PHASE2":97,"PHASE3":99,"PHASE4":101,"NA":112},{"trials":93,"activeCount":94},[],0,{"trials":96,"activeCount":94},[],{"trials":98,"activeCount":94},[],{"trials":100,"activeCount":94},[],{"trials":102,"activeCount":90,"soonestReadout":49},[103],{"nctId":47,"briefTitle":48,"status":104,"phases":105,"primaryCompletion":49,"completion":106,"start":107,"enrollment":108,"conditions":109,"interventions":111},"RECRUITING",[86],"2026-05-01","2024-10-22",10,[110],"Generalized Anxiety Disorder",[50],{"trials":113,"activeCount":94},[],{"intervention":70,"totalTrials":90,"cells":115},{"EARLY_PHASE1":116,"PHASE1":118,"PHASE2":120,"PHASE3":122,"PHASE4":134,"NA":136},{"trials":117,"activeCount":94},[],{"trials":119,"activeCount":94},[],{"trials":121,"activeCount":94},[],{"trials":123,"activeCount":90,"soonestReadout":69},[124],{"nctId":67,"briefTitle":68,"status":125,"phases":126,"primaryCompletion":69,"completion":127,"start":128,"enrollment":129,"conditions":130,"interventions":132},"NOT_YET_RECRUITING",[85],"2029-09-30","2025-10-01",180,[131],"Pelvic Organ Prolapse (POP)",[70,133],"Vaginal Estrogen - Daily",{"trials":135,"activeCount":94},[],{"trials":137,"activeCount":94},[],{"intervention":133,"totalTrials":90,"cells":139},{"EARLY_PHASE1":140,"PHASE1":142,"PHASE2":144,"PHASE3":146,"PHASE4":152,"NA":154},{"trials":141,"activeCount":94},[],{"trials":143,"activeCount":94},[],{"trials":145,"activeCount":94},[],{"trials":147,"activeCount":90,"soonestReadout":69},[148],{"nctId":67,"briefTitle":68,"status":125,"phases":149,"primaryCompletion":69,"completion":127,"start":128,"enrollment":129,"conditions":150,"interventions":151},[85],[131],[70,133],{"trials":153,"activeCount":94},[],{"trials":155,"activeCount":94},[],{"intervention":55,"totalTrials":90,"cells":157},{"EARLY_PHASE1":158,"PHASE1":160,"PHASE2":162,"PHASE3":172,"PHASE4":174,"NA":176},{"trials":159,"activeCount":94},[],{"trials":161,"activeCount":94},[],{"trials":163,"activeCount":90,"soonestReadout":54},[164],{"nctId":52,"briefTitle":53,"status":104,"phases":165,"primaryCompletion":54,"completion":166,"start":167,"enrollment":168,"conditions":169,"interventions":171},[84],"2026-08-30","2025-05-06",50,[170],"Generalized Anxiety Disorder (GAD)",[55],{"trials":173,"activeCount":94},[],{"trials":175,"activeCount":94},[],{"trials":177,"activeCount":94},[],{"intervention":65,"totalTrials":90,"cells":179},{"EARLY_PHASE1":180,"PHASE1":182,"PHASE2":184,"PHASE3":197,"PHASE4":199,"NA":201},{"trials":181,"activeCount":94},[],{"trials":183,"activeCount":94},[],{"trials":185,"activeCount":90,"soonestReadout":64},[186],{"nctId":62,"briefTitle":63,"status":125,"phases":187,"primaryCompletion":64,"completion":64,"start":188,"enrollment":189,"conditions":190,"interventions":195},[83,84],"2025-08-01",31,[191,192,193,194],"NMIBC","Non-Muscle Invasive Bladder Urothelial Carcinoma","Bladder (Urothelial, Transitional Cell) Cancer","Urothelial Carcinoma Bladder",[65,196],"BCG",{"trials":198,"activeCount":94},[],{"trials":200,"activeCount":94},[],{"trials":202,"activeCount":94},[],{"intervention":196,"totalTrials":90,"cells":204},{"EARLY_PHASE1":205,"PHASE1":207,"PHASE2":209,"PHASE3":215,"PHASE4":217,"NA":219},{"trials":206,"activeCount":94},[],{"trials":208,"activeCount":94},[],{"trials":210,"activeCount":90,"soonestReadout":64},[211],{"nctId":62,"briefTitle":63,"status":125,"phases":212,"primaryCompletion":64,"completion":64,"start":188,"enrollment":189,"conditions":213,"interventions":214},[83,84],[191,192,193,194],[65,196],{"trials":216,"activeCount":94},[],{"trials":218,"activeCount":94},[],{"trials":220,"activeCount":94},[],{"intervention":75,"totalTrials":90,"cells":222},{"EARLY_PHASE1":223,"PHASE1":225,"PHASE2":227,"PHASE3":236,"PHASE4":238,"NA":240},{"trials":224,"activeCount":94},[],{"trials":226,"activeCount":94},[],{"trials":228,"activeCount":90,"soonestReadout":74},[229],{"nctId":72,"briefTitle":73,"status":125,"phases":230,"primaryCompletion":74,"completion":74,"start":49,"enrollment":231,"conditions":232,"interventions":235},[84],62,[233,75,234],"Preterm Birth","Neonatal Outcomes",[75],{"trials":237,"activeCount":94},[],{"trials":239,"activeCount":94},[],{"trials":241,"activeCount":94},[],{"intervention":80,"totalTrials":243,"cells":244},3,{"EARLY_PHASE1":245,"PHASE1":247,"PHASE2":249,"PHASE3":270,"PHASE4":272,"NA":274},{"trials":246,"activeCount":94},[],{"trials":248,"activeCount":94},[],{"trials":250,"activeCount":90,"soonestReadout":79},[251,262],{"nctId":252,"briefTitle":253,"status":254,"phases":255,"primaryCompletion":256,"completion":256,"start":257,"enrollment":258,"conditions":259,"interventions":261},"NCT04771767","Combined Ketamine and eCBT Intervention for PTSD","UNKNOWN",[84],"2024-03-31","2021-08-01",16,[260],"Post-Traumatic Stress Disorder",[80],{"nctId":77,"briefTitle":78,"status":125,"phases":263,"primaryCompletion":79,"completion":79,"start":264,"enrollment":265,"conditions":266,"interventions":269},[83,84],"2025-10",30,[267,268],"Chronic Pain","Posttraumatic Stress Disorder (PTSD)",[80],{"trials":271,"activeCount":94},[],{"trials":273,"activeCount":94},[],{"trials":275,"activeCount":94},[276],{"nctId":277,"briefTitle":278,"status":279,"phases":280,"completion":281,"start":282,"enrollment":283,"conditions":284,"interventions":290},"NCT00137085","Ketamine Versus Fentanyl as an Adjunct to Propofol-Assisted Emergency Department Procedural Sedation","COMPLETED",[87],"2006-08","2004-09",124,[285,286,287,288,289],"Fractures","Dislocations","Abscess","Anesthesia","Analgesia",[291],"ketamine",{"intervention":60,"totalTrials":90,"cells":293},{"EARLY_PHASE1":294,"PHASE1":304,"PHASE2":306,"PHASE3":308,"PHASE4":310,"NA":312},{"trials":295,"activeCount":90,"soonestReadout":59},[296],{"nctId":57,"briefTitle":58,"status":104,"phases":297,"primaryCompletion":59,"completion":298,"start":299,"enrollment":300,"conditions":301,"interventions":303},[82],"2027-04-30","2025-05-31",212,[302],"Bleeding Disorder",[60],{"trials":305,"activeCount":94},[],{"trials":307,"activeCount":94},[],{"trials":309,"activeCount":94},[],{"trials":311,"activeCount":94},[],{"trials":313,"activeCount":94},[],{"intervention":40,"totalTrials":90,"cells":315},{"EARLY_PHASE1":316,"PHASE1":318,"PHASE2":320,"PHASE3":322,"PHASE4":324,"NA":326},{"trials":317,"activeCount":94},[],{"trials":319,"activeCount":94},[],{"trials":321,"activeCount":94},[],{"trials":323,"activeCount":94},[],{"trials":325,"activeCount":94},[],{"trials":327,"activeCount":90,"soonestReadout":39},[328],{"nctId":37,"briefTitle":38,"status":329,"phases":330,"primaryCompletion":39,"completion":331,"start":332,"enrollment":333,"conditions":334,"interventions":336},"ACTIVE_NOT_RECRUITING",[87],"2026-04","2024-05-25",2000,[335],"Cervical Cancer",[40,337],"Vaccination Provision 2",{"intervention":337,"totalTrials":90,"cells":339},{"EARLY_PHASE1":340,"PHASE1":342,"PHASE2":344,"PHASE3":346,"PHASE4":348,"NA":350},{"trials":341,"activeCount":94},[],{"trials":343,"activeCount":94},[],{"trials":345,"activeCount":94},[],{"trials":347,"activeCount":94},[],{"trials":349,"activeCount":94},[],{"trials":351,"activeCount":90,"soonestReadout":39},[352],{"nctId":37,"briefTitle":38,"status":329,"phases":353,"primaryCompletion":39,"completion":331,"start":332,"enrollment":333,"conditions":354,"interventions":355},[87],[335],[40,337],{"intervention":45,"totalTrials":90,"cells":357},{"EARLY_PHASE1":358,"PHASE1":360,"PHASE2":362,"PHASE3":364,"PHASE4":366,"NA":368},{"trials":359,"activeCount":94},[],{"trials":361,"activeCount":94},[],{"trials":363,"activeCount":94},[],{"trials":365,"activeCount":94},[],{"trials":367,"activeCount":94},[],{"trials":369,"activeCount":90,"soonestReadout":44},[370],{"nctId":42,"briefTitle":43,"status":329,"phases":371,"primaryCompletion":44,"completion":372,"start":373,"enrollment":10,"conditions":374,"interventions":376},[87],"2026-06","2025-03-04",[375],"Allergic Rhinitis",[45],{"intervention":378,"totalTrials":379,"cells":380},"Picosalax",4,{"EARLY_PHASE1":381,"PHASE1":383,"PHASE2":385,"PHASE3":387,"PHASE4":403,"NA":443},{"trials":382,"activeCount":94},[],{"trials":384,"activeCount":94},[],{"trials":386,"activeCount":94},[],{"trials":388,"activeCount":94},[389],{"nctId":390,"briefTitle":391,"status":279,"phases":392,"primaryCompletion":393,"completion":393,"start":394,"enrollment":10,"conditions":395,"interventions":399},"NCT01655095","Improving Bowel Preparation for the Colon Capsule",[85],"2012-10","2012-07",[396,397,398],"Quality of Bowel Preparation for the Colon Capsule","Colon Capsule Completion Rates","Colon Capsule Polyp Detection",[400,401,378,402],"PEG","Prucalopride","Bisacodyl",{"trials":404,"activeCount":94},[405,418,431],{"nctId":406,"briefTitle":407,"status":279,"phases":408,"primaryCompletion":409,"completion":410,"start":411,"enrollment":412,"conditions":413,"interventions":415},"NCT00677794","Small Bowel Cleansing Prior to Video Capsule Endoscopy Examination",[86],"2013-08","2015-06","2008-03",198,[414],"Endoscopy",[416,378,417],"Clear fluids","Polyethylene glycol",{"nctId":419,"briefTitle":420,"status":279,"phases":421,"primaryCompletion":422,"completion":422,"start":423,"enrollment":424,"conditions":425,"interventions":427},"NCT00410215","A Randomized Controlled Trial Comparing Picosalax and Oral Sodium Phosphate for Colon Cleansing Prior to Colonoscopy",[86],"2008-01","2006-02",315,[426],"Colonoscopy",[428,429,430],"picosalax plus bisacodyl","picosalax","sodium phosphate",{"nctId":432,"briefTitle":433,"status":434,"phases":435,"primaryCompletion":436,"completion":436,"start":437,"enrollment":438,"conditions":439,"interventions":441},"NCT02070341","Patient Tolerability and Efficacy of Bowel Preparation With Split Dose Picosalax vs. Split Dose PEG","TERMINATED",[86],"2014-07","2014-02",5,[440],"Bowel Preparation",[442,378],"Polyethylene Glycol",{"trials":444,"activeCount":94},[],{"intervention":417,"totalTrials":446,"cells":447},2,{"EARLY_PHASE1":448,"PHASE1":450,"PHASE2":452,"PHASE3":454,"PHASE4":456,"NA":466},{"trials":449,"activeCount":94},[],{"trials":451,"activeCount":94},[],{"trials":453,"activeCount":94},[],{"trials":455,"activeCount":94},[],{"trials":457,"activeCount":94},[458,462],{"nctId":406,"briefTitle":407,"status":279,"phases":459,"primaryCompletion":409,"completion":410,"start":411,"enrollment":412,"conditions":460,"interventions":461},[86],[414],[416,378,417],{"nctId":432,"briefTitle":433,"status":434,"phases":463,"primaryCompletion":436,"completion":436,"start":437,"enrollment":438,"conditions":464,"interventions":465},[86],[440],[442,378],{"trials":467,"activeCount":94},[],{"intervention":469,"totalTrials":446,"cells":470},"Atorvastatin",{"EARLY_PHASE1":471,"PHASE1":473,"PHASE2":475,"PHASE3":485,"PHASE4":487,"NA":502},{"trials":472,"activeCount":94},[],{"trials":474,"activeCount":94},[],{"trials":476,"activeCount":94},[477],{"nctId":478,"briefTitle":479,"status":434,"phases":480,"primaryCompletion":481,"completion":410,"start":423,"enrollment":108,"conditions":482,"interventions":484},"NCT00292201","Statin Treatment in Patients With Asthma",[84],"2013-06",[483],"Asthma",[469],{"trials":486,"activeCount":94},[],{"trials":488,"activeCount":94},[489],{"nctId":490,"briefTitle":491,"status":279,"phases":492,"primaryCompletion":493,"completion":493,"start":494,"enrollment":495,"conditions":496,"interventions":499},"NCT00665834","Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome",[86],"2007-09","2006-04",18,[497,498],"Dyslipidemia","Acute Coronary Syndromes",[500,500,501],"rosuvastatin","atorvastatin",{"trials":503,"activeCount":94},[],{"intervention":505,"totalTrials":446,"cells":506},"Pico-Salax",{"EARLY_PHASE1":507,"PHASE1":509,"PHASE2":511,"PHASE3":513,"PHASE4":515,"NA":538},{"trials":508,"activeCount":94},[],{"trials":510,"activeCount":94},[],{"trials":512,"activeCount":94},[],{"trials":514,"activeCount":94},[],{"trials":516,"activeCount":94},[517,528],{"nctId":518,"briefTitle":519,"status":279,"phases":520,"primaryCompletion":521,"completion":522,"start":523,"enrollment":524,"conditions":525,"interventions":526},"NCT00885274","A Randomized Controlled Trial Comparing Two Timing Regimens of Pico-salax for Colon Cleansing Prior to Colonoscopy",[86],"2011-03","2011-08","2008-11",250,[426],[505,527],"Split Dose Pico-Salax",{"nctId":529,"briefTitle":530,"status":279,"phases":531,"primaryCompletion":532,"completion":533,"start":532,"enrollment":10,"conditions":534,"interventions":537},"NCT00885430","Pico-Salax Colonic Preparation Study: Quantifying Electrolyte and Volume Status Changes",[86],"2008-07","2008-09",[535,536],"Hemodynamics","Hyponatremia",[505],{"trials":539,"activeCount":94},[],{"intervention":541,"totalTrials":446,"cells":542},"Pregabalin",{"EARLY_PHASE1":543,"PHASE1":545,"PHASE2":547,"PHASE3":549,"PHASE4":561,"NA":572},{"trials":544,"activeCount":94},[],{"trials":546,"activeCount":94},[],{"trials":548,"activeCount":94},[],{"trials":550,"activeCount":94},[551],{"nctId":552,"briefTitle":553,"status":554,"phases":555,"primaryCompletion":556,"completion":557,"start":558,"enrollment":94,"conditions":559,"interventions":560},"NCT00998816","The Effect of Perioperative Pregabalin on the Incidence of Chronic Post-thoracotomy Pain Syndrome","WITHDRAWN",[85],"2014-08","2014-10","2012-05",[267],[541],{"trials":562,"activeCount":94},[563],{"nctId":564,"briefTitle":565,"status":279,"phases":566,"primaryCompletion":523,"completion":567,"start":568,"enrollment":569,"conditions":570,"interventions":571},"NCT00663962","Pregabalin and Post-thoracotomy Pain",[86],"2009-05","2008-04",15,[267],[541],{"trials":573,"activeCount":94},[],{"intervention":575,"totalTrials":90,"cells":576},"Cetirizine",{"EARLY_PHASE1":577,"PHASE1":579,"PHASE2":581,"PHASE3":583,"PHASE4":585,"NA":597},{"trials":578,"activeCount":94},[],{"trials":580,"activeCount":94},[],{"trials":582,"activeCount":94},[],{"trials":584,"activeCount":94},[],{"trials":586,"activeCount":94},[587],{"nctId":588,"briefTitle":589,"status":279,"phases":590,"primaryCompletion":591,"completion":592,"start":593,"enrollment":594,"conditions":595,"interventions":596},"NCT02543346","Comparability and Standardization of Controlled Allergen Challenge Facilities",[86],"2016-02","2016-05","2015-10",98,[375],[575],{"trials":598,"activeCount":94},[],{"intervention":600,"totalTrials":90,"cells":601},"Nepafenac 0.1%",{"EARLY_PHASE1":602,"PHASE1":604,"PHASE2":606,"PHASE3":608,"PHASE4":610,"NA":623},{"trials":603,"activeCount":94},[],{"trials":605,"activeCount":94},[],{"trials":607,"activeCount":94},[],{"trials":609,"activeCount":94},[],{"trials":611,"activeCount":94},[612],{"nctId":613,"briefTitle":614,"status":279,"phases":615,"primaryCompletion":616,"completion":616,"start":617,"enrollment":618,"conditions":619,"interventions":621},"NCT01395069","Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery",[86],"2011-05","2010-02",162,[620],"Macular Edema",[600,622],"Ketorolac 0.5%",{"trials":624,"activeCount":94},[],{"intervention":416,"totalTrials":90,"cells":626},{"EARLY_PHASE1":627,"PHASE1":629,"PHASE2":631,"PHASE3":633,"PHASE4":635,"NA":641},{"trials":628,"activeCount":94},[],{"trials":630,"activeCount":94},[],{"trials":632,"activeCount":94},[],{"trials":634,"activeCount":94},[],{"trials":636,"activeCount":94},[637],{"nctId":406,"briefTitle":407,"status":279,"phases":638,"primaryCompletion":409,"completion":410,"start":411,"enrollment":412,"conditions":639,"interventions":640},[86],[414],[416,378,417],{"trials":642,"activeCount":94},[],{"intervention":644,"totalTrials":90,"cells":645},"Indomethacin",{"EARLY_PHASE1":646,"PHASE1":648,"PHASE2":650,"PHASE3":652,"PHASE4":654,"NA":668},{"trials":647,"activeCount":94},[],{"trials":649,"activeCount":94},[],{"trials":651,"activeCount":94},[],{"trials":653,"activeCount":94},[],{"trials":655,"activeCount":94},[656],{"nctId":657,"briefTitle":658,"status":279,"phases":659,"primaryCompletion":660,"completion":660,"start":661,"enrollment":662,"conditions":663,"interventions":665},"NCT01073670","Indomethacin and Cardiac Bypass Surgery",[86],"2002-04","2000-08",82,[664],"Hemorrhage",[644,666,667],"Acetaminophen & Indomethacin","Acetaminophen",{"trials":669,"activeCount":94},[],{"intervention":666,"totalTrials":90,"cells":671},{"EARLY_PHASE1":672,"PHASE1":674,"PHASE2":676,"PHASE3":678,"PHASE4":680,"NA":686},{"trials":673,"activeCount":94},[],{"trials":675,"activeCount":94},[],{"trials":677,"activeCount":94},[],{"trials":679,"activeCount":94},[],{"trials":681,"activeCount":94},[682],{"nctId":657,"briefTitle":658,"status":279,"phases":683,"primaryCompletion":660,"completion":660,"start":661,"enrollment":662,"conditions":684,"interventions":685},[86],[664],[644,666,667],{"trials":687,"activeCount":94},[],{"intervention":667,"totalTrials":90,"cells":689},{"EARLY_PHASE1":690,"PHASE1":692,"PHASE2":694,"PHASE3":696,"PHASE4":698,"NA":704},{"trials":691,"activeCount":94},[],{"trials":693,"activeCount":94},[],{"trials":695,"activeCount":94},[],{"trials":697,"activeCount":94},[],{"trials":699,"activeCount":94},[700],{"nctId":657,"briefTitle":658,"status":279,"phases":701,"primaryCompletion":660,"completion":660,"start":661,"enrollment":662,"conditions":702,"interventions":703},[86],[664],[644,666,667],{"trials":705,"activeCount":94},[],{"intervention":707,"totalTrials":90,"cells":708},"Budesonide",{"EARLY_PHASE1":709,"PHASE1":711,"PHASE2":713,"PHASE3":715,"PHASE4":717,"NA":727},{"trials":710,"activeCount":94},[],{"trials":712,"activeCount":94},[],{"trials":714,"activeCount":94},[],{"trials":716,"activeCount":94},[],{"trials":718,"activeCount":94},[719],{"nctId":720,"briefTitle":721,"status":279,"phases":722,"primaryCompletion":723,"completion":723,"start":724,"enrollment":379,"conditions":725,"interventions":726},"NCT00202189","Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)",[86],"2005-11","2005-09",[25],[707],{"trials":728,"activeCount":94},[],{"intervention":730,"totalTrials":90,"cells":731},"ACL\u002FFOR",{"EARLY_PHASE1":732,"PHASE1":734,"PHASE2":736,"PHASE3":738,"PHASE4":740,"NA":751},{"trials":733,"activeCount":94},[],{"trials":735,"activeCount":94},[],{"trials":737,"activeCount":94},[],{"trials":739,"activeCount":94},[],{"trials":741,"activeCount":94},[742],{"nctId":743,"briefTitle":744,"status":279,"phases":745,"primaryCompletion":746,"completion":746,"start":593,"enrollment":747,"conditions":748,"interventions":750},"NCT02429765","Effect of Aclidinium\u002FFormoterol on Nighttime Lung Function and Morning Symptoms in Chronic Obstructive Pulmonary Disease",[86],"2018-08",40,[749],"COPD",[730],{"trials":752,"activeCount":94},[],{"intervention":754,"totalTrials":90,"cells":755},"ziprasidone hydrochloride",{"EARLY_PHASE1":756,"PHASE1":758,"PHASE2":760,"PHASE3":762,"PHASE4":764,"NA":776},{"trials":757,"activeCount":94},[],{"trials":759,"activeCount":94},[],{"trials":761,"activeCount":94},[],{"trials":763,"activeCount":94},[],{"trials":765,"activeCount":94},[766],{"nctId":767,"briefTitle":768,"status":279,"phases":769,"primaryCompletion":770,"completion":770,"start":771,"enrollment":772,"conditions":773,"interventions":775},"NCT00835107","An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression",[86],"2011-06","2009-02",14,[774],"Depression, Bipolar",[754],{"trials":777,"activeCount":94},[],{"intervention":779,"totalTrials":90,"cells":780},"N-acetylcysteine",{"EARLY_PHASE1":781,"PHASE1":783,"PHASE2":785,"PHASE3":787,"PHASE4":789,"NA":799},{"trials":782,"activeCount":94},[],{"trials":784,"activeCount":94},[],{"trials":786,"activeCount":94},[],{"trials":788,"activeCount":94},[],{"trials":790,"activeCount":94},[791],{"nctId":792,"briefTitle":793,"status":279,"phases":794,"primaryCompletion":592,"completion":592,"start":795,"enrollment":17,"conditions":796,"interventions":798},"NCT02579772","Effects of N-acetylcysteine on Cardiorespiratory Control in COPD Patients With Mild-to-moderate Airflow Obstruction",[86],"2015-07",[797],"Pulmonary Disease, Chronic Obstructive",[779],{"trials":800,"activeCount":94},[],{"intervention":527,"totalTrials":90,"cells":802},{"EARLY_PHASE1":803,"PHASE1":805,"PHASE2":807,"PHASE3":809,"PHASE4":811,"NA":817},{"trials":804,"activeCount":94},[],{"trials":806,"activeCount":94},[],{"trials":808,"activeCount":94},[],{"trials":810,"activeCount":94},[],{"trials":812,"activeCount":94},[813],{"nctId":518,"briefTitle":519,"status":279,"phases":814,"primaryCompletion":521,"completion":522,"start":523,"enrollment":524,"conditions":815,"interventions":816},[86],[426],[505,527],{"trials":818,"activeCount":94},[],{"intervention":820,"totalTrials":90,"cells":821},"Triamcinalone (steroid) and lidocaine",{"EARLY_PHASE1":822,"PHASE1":824,"PHASE2":826,"PHASE3":828,"PHASE4":830,"NA":842},{"trials":823,"activeCount":94},[],{"trials":825,"activeCount":94},[],{"trials":827,"activeCount":94},[],{"trials":829,"activeCount":94},[],{"trials":831,"activeCount":94},[832],{"nctId":833,"briefTitle":834,"status":279,"phases":835,"primaryCompletion":836,"completion":836,"start":837,"enrollment":838,"conditions":839,"interventions":841},"NCT02001740","An RCT in Treatment of Adhesive Capsulitis Arthrographic Joint Distention With Local Anesthetic Alone",[86],"2015-03","2012-12",108,[840],"Adhesive Capsulitis",[820],{"trials":843,"activeCount":94},[],{"intervention":845,"totalTrials":90,"cells":846},"diclofenac",{"EARLY_PHASE1":847,"PHASE1":849,"PHASE2":851,"PHASE3":853,"PHASE4":855,"NA":867},{"trials":848,"activeCount":94},[],{"trials":850,"activeCount":94},[],{"trials":852,"activeCount":94},[],{"trials":854,"activeCount":94},[],{"trials":856,"activeCount":94},[857],{"nctId":858,"briefTitle":859,"status":434,"phases":860,"primaryCompletion":861,"completion":861,"start":862,"enrollment":863,"conditions":864,"interventions":866},"NCT00428025","Diclofenac for the Prevention of Post-ERCP Pancreatitis in Higher Risk Patients",[86],"2008-10","2006-10",23,[865],"Pancreatitis",[845],{"trials":868,"activeCount":94},[],{"intervention":870,"totalTrials":90,"cells":871},"Ipratropium Bromide",{"EARLY_PHASE1":872,"PHASE1":874,"PHASE2":876,"PHASE3":878,"PHASE4":880,"NA":892},{"trials":873,"activeCount":94},[],{"trials":875,"activeCount":94},[],{"trials":877,"activeCount":94},[],{"trials":879,"activeCount":94},[],{"trials":881,"activeCount":94},[882],{"nctId":883,"briefTitle":884,"status":279,"phases":885,"primaryCompletion":886,"completion":886,"start":887,"enrollment":888,"conditions":889,"interventions":891},"NCT00202176","Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD)",[86],"2008-12","2005-07",32,[890],"Chronic Obstructive Pulmonary Disease (COPD)",[870],{"trials":893,"activeCount":94},[],{"intervention":895,"totalTrials":90,"cells":896},"Grastek®",{"EARLY_PHASE1":897,"PHASE1":899,"PHASE2":901,"PHASE3":903,"PHASE4":905,"NA":918},{"trials":898,"activeCount":94},[],{"trials":900,"activeCount":94},[],{"trials":902,"activeCount":94},[],{"trials":904,"activeCount":94},[],{"trials":906,"activeCount":94},[907],{"nctId":908,"briefTitle":909,"status":279,"phases":910,"primaryCompletion":911,"completion":912,"start":913,"enrollment":914,"conditions":915,"interventions":917},"NCT02394600","The Impact of Grass SLIT Treatment on Birch Pollen Induced Allergic Rhinitis - a Pilot Evaluation",[86],"2016-04","2016-06","2015-04",93,[916],"Allergic Rhinoconjunctivitis",[895],{"trials":919,"activeCount":94},[],{"intervention":921,"totalTrials":90,"cells":922},"Combivent",{"EARLY_PHASE1":923,"PHASE1":925,"PHASE2":927,"PHASE3":929,"PHASE4":931,"NA":941},{"trials":924,"activeCount":94},[],{"trials":926,"activeCount":94},[],{"trials":928,"activeCount":94},[],{"trials":930,"activeCount":94},[],{"trials":932,"activeCount":94},[933],{"nctId":934,"briefTitle":935,"status":279,"phases":936,"primaryCompletion":937,"completion":937,"start":938,"enrollment":12,"conditions":939,"interventions":940},"NCT00354354","Bronchodilators and Oxygen Kinetics With Exercise in Chronic Obstructive Pulmonary Disease (COPD) Patients",[86],"2009-07","2006-03",[25],[921],{"trials":942,"activeCount":94},[],{"intervention":944,"totalTrials":90,"cells":945},"Tiotropium + Olodaterol",{"EARLY_PHASE1":946,"PHASE1":948,"PHASE2":950,"PHASE3":952,"PHASE4":954,"NA":965},{"trials":947,"activeCount":94},[],{"trials":949,"activeCount":94},[],{"trials":951,"activeCount":94},[],{"trials":953,"activeCount":94},[],{"trials":955,"activeCount":94},[956],{"nctId":957,"briefTitle":958,"status":279,"phases":959,"primaryCompletion":960,"completion":960,"start":961,"enrollment":962,"conditions":963,"interventions":964},"NCT03425617","Effects of Dual Bronchodilator Treatment on Cardiopulmonary Interactions in COPD",[86],"2018-06-30","2017-01-01",25,[25],[944],{"trials":966,"activeCount":94},[],{"intervention":968,"totalTrials":90,"cells":969},"Tryptophan",{"EARLY_PHASE1":970,"PHASE1":972,"PHASE2":974,"PHASE3":976,"PHASE4":978,"NA":989},{"trials":971,"activeCount":94},[],{"trials":973,"activeCount":94},[],{"trials":975,"activeCount":94},[],{"trials":977,"activeCount":94},[],{"trials":979,"activeCount":94},[980],{"nctId":981,"briefTitle":982,"status":279,"phases":983,"completion":984,"start":985,"enrollment":12,"conditions":986,"interventions":988},"NCT00202124","Double Blind Study of Trp01 in Patients With Alzheimer's Disease",[86],"2002-03","2001-04",[987],"Alzheimer's Disease",[968],{"trials":990,"activeCount":94},[],{"intervention":992,"totalTrials":90,"cells":993},"cofactor supplementation",{"EARLY_PHASE1":994,"PHASE1":996,"PHASE2":998,"PHASE3":1000,"PHASE4":1002,"NA":1016},{"trials":995,"activeCount":94},[],{"trials":997,"activeCount":94},[],{"trials":999,"activeCount":94},[],{"trials":1001,"activeCount":94},[],{"trials":1003,"activeCount":94},[1004],{"nctId":1005,"briefTitle":1006,"status":279,"phases":1007,"primaryCompletion":861,"completion":1008,"start":1009,"enrollment":265,"conditions":1010,"interventions":1015},"NCT00202228","Lactate Metabolism Study in HIV Infected Persons",[86],"2011-09","2002-07",[1011,1012,1013,1014],"HIV Infections","AIDS","Lactic Acidosis","Lipodystrophy",[992],{"trials":1017,"activeCount":94},[],{"intervention":428,"totalTrials":90,"cells":1019},{"EARLY_PHASE1":1020,"PHASE1":1022,"PHASE2":1024,"PHASE3":1026,"PHASE4":1028,"NA":1034},{"trials":1021,"activeCount":94},[],{"trials":1023,"activeCount":94},[],{"trials":1025,"activeCount":94},[],{"trials":1027,"activeCount":94},[],{"trials":1029,"activeCount":94},[1030],{"nctId":419,"briefTitle":420,"status":279,"phases":1031,"primaryCompletion":422,"completion":422,"start":423,"enrollment":424,"conditions":1032,"interventions":1033},[86],[426],[428,429,430],{"trials":1035,"activeCount":94},[],{"intervention":430,"totalTrials":90,"cells":1037},{"EARLY_PHASE1":1038,"PHASE1":1040,"PHASE2":1042,"PHASE3":1044,"PHASE4":1046,"NA":1052},{"trials":1039,"activeCount":94},[],{"trials":1041,"activeCount":94},[],{"trials":1043,"activeCount":94},[],{"trials":1045,"activeCount":94},[],{"trials":1047,"activeCount":94},[1048],{"nctId":419,"briefTitle":420,"status":279,"phases":1049,"primaryCompletion":422,"completion":422,"start":423,"enrollment":424,"conditions":1050,"interventions":1051},[86],[426],[428,429,430],{"trials":1053,"activeCount":94},[],{"intervention":1055,"totalTrials":90,"cells":1056},"Picosulfate sodium,",{"EARLY_PHASE1":1057,"PHASE1":1059,"PHASE2":1061,"PHASE3":1063,"PHASE4":1065,"NA":1079},{"trials":1058,"activeCount":94},[],{"trials":1060,"activeCount":94},[],{"trials":1062,"activeCount":94},[],{"trials":1064,"activeCount":94},[],{"trials":1066,"activeCount":94},[1067],{"nctId":1068,"briefTitle":1069,"status":279,"phases":1070,"primaryCompletion":1071,"completion":1071,"start":1072,"enrollment":1073,"conditions":1074,"interventions":1076},"NCT01554111","Comparing Bowel Preparation Regimens for Flexible Sigmoidoscopy",[86],"2015-09","2012-03",120,[1075],"Cathartic Colon",[1055,1077,1078],"phosphosoda rectal enema","Pico-Salax and Sodium phosphate enema",{"trials":1080,"activeCount":94},[],{"intervention":1077,"totalTrials":90,"cells":1082},{"EARLY_PHASE1":1083,"PHASE1":1085,"PHASE2":1087,"PHASE3":1089,"PHASE4":1091,"NA":1097},{"trials":1084,"activeCount":94},[],{"trials":1086,"activeCount":94},[],{"trials":1088,"activeCount":94},[],{"trials":1090,"activeCount":94},[],{"trials":1092,"activeCount":94},[1093],{"nctId":1068,"briefTitle":1069,"status":279,"phases":1094,"primaryCompletion":1071,"completion":1071,"start":1072,"enrollment":1073,"conditions":1095,"interventions":1096},[86],[1075],[1055,1077,1078],{"trials":1098,"activeCount":94},[],{"intervention":1078,"totalTrials":90,"cells":1100},{"EARLY_PHASE1":1101,"PHASE1":1103,"PHASE2":1105,"PHASE3":1107,"PHASE4":1109,"NA":1115},{"trials":1102,"activeCount":94},[],{"trials":1104,"activeCount":94},[],{"trials":1106,"activeCount":94},[],{"trials":1108,"activeCount":94},[],{"trials":1110,"activeCount":94},[1111],{"nctId":1068,"briefTitle":1069,"status":279,"phases":1112,"primaryCompletion":1071,"completion":1071,"start":1072,"enrollment":1073,"conditions":1113,"interventions":1114},[86],[1075],[1055,1077,1078],{"trials":1116,"activeCount":94},[],{"intervention":1118,"totalTrials":90,"cells":1119},"Gabapentin",{"EARLY_PHASE1":1120,"PHASE1":1122,"PHASE2":1124,"PHASE3":1126,"PHASE4":1128,"NA":1138},{"trials":1121,"activeCount":94},[],{"trials":1123,"activeCount":94},[],{"trials":1125,"activeCount":94},[],{"trials":1127,"activeCount":94},[],{"trials":1129,"activeCount":94},[1130],{"nctId":1131,"briefTitle":1132,"status":279,"phases":1133,"primaryCompletion":493,"completion":493,"start":1134,"enrollment":258,"conditions":1135,"interventions":1137},"NCT01022736","Plasma Gabapentin Concentration During and Following Cardiac Bypass",[86],"2007-05",[1136],"Cardiopulmonary Bypass",[1118],{"trials":1139,"activeCount":94},[],{"intervention":1141,"totalTrials":90,"cells":1142},"Olanzapine",{"EARLY_PHASE1":1143,"PHASE1":1145,"PHASE2":1147,"PHASE3":1149,"PHASE4":1151,"NA":1163},{"trials":1144,"activeCount":94},[],{"trials":1146,"activeCount":94},[],{"trials":1148,"activeCount":94},[],{"trials":1150,"activeCount":94},[],{"trials":1152,"activeCount":94},[1153],{"nctId":1154,"briefTitle":1155,"status":279,"phases":1156,"primaryCompletion":567,"completion":567,"start":1157,"enrollment":1158,"conditions":1159,"interventions":1162},"NCT00520507","An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients",[86],"2007-10",27,[1160,16,1161],"Bipolar Disorder","Depressive Disorder",[1141],{"trials":1164,"activeCount":94},[],{"intervention":1166,"totalTrials":90,"cells":1167},"Magnesium Sulfate",{"EARLY_PHASE1":1168,"PHASE1":1170,"PHASE2":1172,"PHASE3":1174,"PHASE4":1176,"NA":1188},{"trials":1169,"activeCount":94},[],{"trials":1171,"activeCount":94},[],{"trials":1173,"activeCount":94},[],{"trials":1175,"activeCount":94},[],{"trials":1177,"activeCount":94},[1178],{"nctId":1179,"briefTitle":1180,"status":279,"phases":1181,"primaryCompletion":1182,"completion":1182,"start":1071,"enrollment":1183,"conditions":1184,"interventions":1186},"NCT02581683","Magnesium Sulfate in Adductor Canal Blocks",[86],"2017-02",130,[1185],"Knee Arthroplasty",[1166,1187],"Ropivacaine",{"trials":1189,"activeCount":94},[],{"intervention":1187,"totalTrials":90,"cells":1191},{"EARLY_PHASE1":1192,"PHASE1":1194,"PHASE2":1196,"PHASE3":1198,"PHASE4":1200,"NA":1206},{"trials":1193,"activeCount":94},[],{"trials":1195,"activeCount":94},[],{"trials":1197,"activeCount":94},[],{"trials":1199,"activeCount":94},[],{"trials":1201,"activeCount":94},[1202],{"nctId":1179,"briefTitle":1180,"status":279,"phases":1203,"primaryCompletion":1182,"completion":1182,"start":1071,"enrollment":1183,"conditions":1204,"interventions":1205},[86],[1185],[1166,1187],{"trials":1207,"activeCount":94},[],{"intervention":1209,"totalTrials":90,"cells":1210},"Simvastatin",{"EARLY_PHASE1":1211,"PHASE1":1213,"PHASE2":1215,"PHASE3":1217,"PHASE4":1219,"NA":1228},{"trials":1212,"activeCount":94},[],{"trials":1214,"activeCount":94},[],{"trials":1216,"activeCount":94},[],{"trials":1218,"activeCount":94},[],{"trials":1220,"activeCount":94},[1221],{"nctId":1222,"briefTitle":1223,"status":554,"phases":1224,"primaryCompletion":522,"completion":522,"start":1225,"enrollment":94,"conditions":1226,"interventions":1227},"NCT01047423","Targeting Microvascular Dysfunction in Young Hypertensive Patients",[86],"2009-08",[29],[1209],{"trials":1229,"activeCount":94},[],{"intervention":500,"totalTrials":90,"cells":1231},{"EARLY_PHASE1":1232,"PHASE1":1234,"PHASE2":1236,"PHASE3":1238,"PHASE4":1240,"NA":1246},{"trials":1233,"activeCount":94},[],{"trials":1235,"activeCount":94},[],{"trials":1237,"activeCount":94},[],{"trials":1239,"activeCount":94},[],{"trials":1241,"activeCount":94},[1242],{"nctId":490,"briefTitle":491,"status":279,"phases":1243,"primaryCompletion":493,"completion":493,"start":494,"enrollment":495,"conditions":1244,"interventions":1245},[86],[497,498],[500,500,501],{"trials":1247,"activeCount":94},[],{"intervention":401,"totalTrials":446,"cells":1249},{"EARLY_PHASE1":1250,"PHASE1":1252,"PHASE2":1254,"PHASE3":1256,"PHASE4":1271,"NA":1273},{"trials":1251,"activeCount":94},[],{"trials":1253,"activeCount":94},[],{"trials":1255,"activeCount":94},[],{"trials":1257,"activeCount":94},[1258,1262],{"nctId":390,"briefTitle":391,"status":279,"phases":1259,"primaryCompletion":393,"completion":393,"start":394,"enrollment":10,"conditions":1260,"interventions":1261},[85],[396,397,398],[400,401,378,402],{"nctId":1263,"briefTitle":1264,"status":279,"phases":1265,"primaryCompletion":557,"completion":557,"start":481,"enrollment":1266,"conditions":1267,"interventions":1270},"NCT01864915","Prucalopride + Prucalopride Booster vs. Prucalopride + Picosalax Booster for the Colon Capsule",[85],60,[1268,1269],"Bowel Cleansing","Colon Capsule Completion Times",[401],{"trials":1272,"activeCount":94},[],{"trials":1274,"activeCount":94},[],{"intervention":1276,"totalTrials":90,"cells":1277},"Esomeprazole first",{"EARLY_PHASE1":1278,"PHASE1":1280,"PHASE2":1282,"PHASE3":1284,"PHASE4":1296,"NA":1298},{"trials":1279,"activeCount":94},[],{"trials":1281,"activeCount":94},[],{"trials":1283,"activeCount":94},[],{"trials":1285,"activeCount":94},[1286],{"nctId":1287,"briefTitle":1288,"status":434,"phases":1289,"primaryCompletion":1290,"completion":1291,"start":493,"enrollment":10,"conditions":1292,"interventions":1294},"NCT00542347","Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole",[85],"2017-04","2018-07",[1293],"Gastric Acid",[1276,1295],"Generic omeprazole first",{"trials":1297,"activeCount":94},[],{"trials":1299,"activeCount":94},[],{"intervention":1295,"totalTrials":90,"cells":1301},{"EARLY_PHASE1":1302,"PHASE1":1304,"PHASE2":1306,"PHASE3":1308,"PHASE4":1314,"NA":1316},{"trials":1303,"activeCount":94},[],{"trials":1305,"activeCount":94},[],{"trials":1307,"activeCount":94},[],{"trials":1309,"activeCount":94},[1310],{"nctId":1287,"briefTitle":1288,"status":434,"phases":1311,"primaryCompletion":1290,"completion":1291,"start":493,"enrollment":10,"conditions":1312,"interventions":1313},[85],[1293],[1276,1295],{"trials":1315,"activeCount":94},[],{"trials":1317,"activeCount":94},[],{"intervention":400,"totalTrials":90,"cells":1319},{"EARLY_PHASE1":1320,"PHASE1":1322,"PHASE2":1324,"PHASE3":1326,"PHASE4":1332,"NA":1334},{"trials":1321,"activeCount":94},[],{"trials":1323,"activeCount":94},[],{"trials":1325,"activeCount":94},[],{"trials":1327,"activeCount":94},[1328],{"nctId":390,"briefTitle":391,"status":279,"phases":1329,"primaryCompletion":393,"completion":393,"start":394,"enrollment":10,"conditions":1330,"interventions":1331},[85],[396,397,398],[400,401,378,402],{"trials":1333,"activeCount":94},[],{"trials":1335,"activeCount":94},[],{"intervention":402,"totalTrials":90,"cells":1337},{"EARLY_PHASE1":1338,"PHASE1":1340,"PHASE2":1342,"PHASE3":1344,"PHASE4":1350,"NA":1352},{"trials":1339,"activeCount":94},[],{"trials":1341,"activeCount":94},[],{"trials":1343,"activeCount":94},[],{"trials":1345,"activeCount":94},[1346],{"nctId":390,"briefTitle":391,"status":279,"phases":1347,"primaryCompletion":393,"completion":393,"start":394,"enrollment":10,"conditions":1348,"interventions":1349},[85],[396,397,398],[400,401,378,402],{"trials":1351,"activeCount":94},[],{"trials":1353,"activeCount":94},[],{"intervention":1355,"totalTrials":90,"cells":1356},"magnesium sulfate, bicarbonate, dextrose.",{"EARLY_PHASE1":1357,"PHASE1":1359,"PHASE2":1361,"PHASE3":1363,"PHASE4":1376,"NA":1378},{"trials":1358,"activeCount":94},[],{"trials":1360,"activeCount":94},[],{"trials":1362,"activeCount":94},[],{"trials":1364,"activeCount":94},[1365],{"nctId":1366,"briefTitle":1367,"status":434,"phases":1368,"primaryCompletion":1369,"completion":1370,"start":911,"enrollment":1371,"conditions":1372,"interventions":1374},"NCT02728037","Magnesium-Based Trigger Point Injections for Relief of Chronic Myofascial Pelvic Pain",[85],"2020-03","2020-04",38,[1373],"Pelvic Pain",[1375,1355],"lidocaine",{"trials":1377,"activeCount":94},[],{"trials":1379,"activeCount":94},[],{"intervention":1381,"totalTrials":90,"cells":1382},"LAMA\u002FLABA",{"EARLY_PHASE1":1383,"PHASE1":1385,"PHASE2":1387,"PHASE3":1389,"PHASE4":1401,"NA":1403},{"trials":1384,"activeCount":94},[],{"trials":1386,"activeCount":94},[],{"trials":1388,"activeCount":94},[],{"trials":1390,"activeCount":94},[1391],{"nctId":1392,"briefTitle":1393,"status":279,"phases":1394,"primaryCompletion":1395,"completion":1395,"start":1396,"enrollment":1397,"conditions":1398,"interventions":1399},"NCT01491802","Effect of a New Combination Bronchodilator on Exercise in GOLD Stage II Moderate COPD",[85],"2014-09","2012-01",17,[749],[1381,1400],"LAMA",{"trials":1402,"activeCount":94},[],{"trials":1404,"activeCount":94},[],{"intervention":1400,"totalTrials":90,"cells":1406},{"EARLY_PHASE1":1407,"PHASE1":1409,"PHASE2":1411,"PHASE3":1413,"PHASE4":1419,"NA":1421},{"trials":1408,"activeCount":94},[],{"trials":1410,"activeCount":94},[],{"trials":1412,"activeCount":94},[],{"trials":1414,"activeCount":94},[1415],{"nctId":1392,"briefTitle":1393,"status":279,"phases":1416,"primaryCompletion":1395,"completion":1395,"start":1396,"enrollment":1397,"conditions":1417,"interventions":1418},[85],[749],[1381,1400],{"trials":1420,"activeCount":94},[],{"trials":1422,"activeCount":94},[],{"intervention":1424,"totalTrials":90,"cells":1425},"Bevacizumab",{"EARLY_PHASE1":1426,"PHASE1":1428,"PHASE2":1430,"PHASE3":1432,"PHASE4":1444,"NA":1446},{"trials":1427,"activeCount":94},[],{"trials":1429,"activeCount":94},[],{"trials":1431,"activeCount":94},[],{"trials":1433,"activeCount":94},[1434],{"nctId":1435,"briefTitle":1436,"status":279,"phases":1437,"primaryCompletion":1438,"completion":409,"start":1439,"enrollment":108,"conditions":1440,"interventions":1442},"NCT01661946","Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye",[85],"2013-07","2012-08",[1441],"Diabetic Macular Edema",[1424,1443],"Ranibizumab",{"trials":1445,"activeCount":94},[],{"trials":1447,"activeCount":94},[],{"intervention":1443,"totalTrials":90,"cells":1449},{"EARLY_PHASE1":1450,"PHASE1":1452,"PHASE2":1454,"PHASE3":1456,"PHASE4":1462,"NA":1464},{"trials":1451,"activeCount":94},[],{"trials":1453,"activeCount":94},[],{"trials":1455,"activeCount":94},[],{"trials":1457,"activeCount":94},[1458],{"nctId":1435,"briefTitle":1436,"status":279,"phases":1459,"primaryCompletion":1438,"completion":409,"start":1439,"enrollment":108,"conditions":1460,"interventions":1461},[85],[1441],[1424,1443],{"trials":1463,"activeCount":94},[],{"trials":1465,"activeCount":94},[],{"intervention":1467,"totalTrials":90,"cells":1468},"erythropoietin",{"EARLY_PHASE1":1469,"PHASE1":1471,"PHASE2":1473,"PHASE3":1475,"PHASE4":1485,"NA":1487},{"trials":1470,"activeCount":94},[],{"trials":1472,"activeCount":94},[],{"trials":1474,"activeCount":94},[],{"trials":1476,"activeCount":94},[1477],{"nctId":1478,"briefTitle":1479,"status":434,"phases":1480,"primaryCompletion":771,"completion":771,"start":862,"enrollment":30,"conditions":1481,"interventions":1484},"NCT00319150","REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial",[85],[1482,1483],"Kidney Failure, Chronic","Drug Resistance",[1467],{"trials":1486,"activeCount":94},[],{"trials":1488,"activeCount":94},[],{"intervention":1490,"totalTrials":90,"cells":1491},"Tetracaine 0.5% ophthalmic drops",{"EARLY_PHASE1":1492,"PHASE1":1494,"PHASE2":1496,"PHASE3":1498,"PHASE4":1509,"NA":1511},{"trials":1493,"activeCount":94},[],{"trials":1495,"activeCount":94},[],{"trials":1497,"activeCount":94},[],{"trials":1499,"activeCount":94},[1500],{"nctId":1501,"briefTitle":1502,"status":554,"phases":1503,"primaryCompletion":1504,"completion":1504,"start":410,"enrollment":94,"conditions":1505,"interventions":1507},"NCT02483897","Effect of Tetracaine on Pain Management and Corneal Healing in Patients With Acute Corneal Abrasion",[85],"2015-08",[1506],"Corneal Abrasion",[1490,1508],"Normal Saline placebo drops",{"trials":1510,"activeCount":94},[],{"trials":1512,"activeCount":94},[],{"intervention":1508,"totalTrials":90,"cells":1514},{"EARLY_PHASE1":1515,"PHASE1":1517,"PHASE2":1519,"PHASE3":1521,"PHASE4":1527,"NA":1529},{"trials":1516,"activeCount":94},[],{"trials":1518,"activeCount":94},[],{"trials":1520,"activeCount":94},[],{"trials":1522,"activeCount":94},[1523],{"nctId":1501,"briefTitle":1502,"status":554,"phases":1524,"primaryCompletion":1504,"completion":1504,"start":410,"enrollment":94,"conditions":1525,"interventions":1526},[85],[1506],[1490,1508],{"trials":1528,"activeCount":94},[],{"trials":1530,"activeCount":94},[],{"intervention":1532,"totalTrials":90,"cells":1533},"Bisphosphonate",{"EARLY_PHASE1":1534,"PHASE1":1536,"PHASE2":1538,"PHASE3":1540,"PHASE4":1549,"NA":1551},{"trials":1535,"activeCount":94},[],{"trials":1537,"activeCount":94},[],{"trials":1539,"activeCount":94},[],{"trials":1541,"activeCount":94},[1542],{"nctId":1543,"briefTitle":1544,"status":279,"phases":1545,"primaryCompletion":481,"completion":481,"start":861,"enrollment":962,"conditions":1546,"interventions":1548},"NCT00687661","Queen's University Investigation of Calcification in Chronic Kidney Disease",[85],[1547],"Chronic Kidney Disease",[1532],{"trials":1550,"activeCount":94},[],{"trials":1552,"activeCount":94},[],{"intervention":1554,"totalTrials":90,"cells":1555},"Autoregulation-based precision blood pressure management",{"EARLY_PHASE1":1556,"PHASE1":1558,"PHASE2":1560,"PHASE3":1574,"PHASE4":1576,"NA":1578},{"trials":1557,"activeCount":94},[],{"trials":1559,"activeCount":94},[],{"trials":1561,"activeCount":94},[1562],{"nctId":1563,"briefTitle":1564,"status":279,"phases":1565,"primaryCompletion":1566,"completion":1566,"start":1567,"enrollment":258,"conditions":1568,"interventions":1573},"NCT07296029","CONFOCAL-2 Interventional Pilot Study",[83,84],"2025-02-08","2022-07-29",[1569,1570,1571,1572],"Critical Illness","Respiratory Failure","Shock","Delirium",[1554],{"trials":1575,"activeCount":94},[],{"trials":1577,"activeCount":94},[],{"trials":1579,"activeCount":94},[],{"intervention":1581,"totalTrials":90,"cells":1582},"DHEA",{"EARLY_PHASE1":1583,"PHASE1":1585,"PHASE2":1587,"PHASE3":1599,"PHASE4":1601,"NA":1603},{"trials":1584,"activeCount":94},[],{"trials":1586,"activeCount":94},[],{"trials":1588,"activeCount":94},[1589],{"nctId":1590,"briefTitle":1591,"status":279,"phases":1592,"primaryCompletion":1593,"completion":493,"start":1594,"enrollment":1073,"conditions":1595,"interventions":1597},"NCT00202163","ANDRO 2002: Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual Dysfunction",[84],"2007-07","2006-12",[1596],"Erectile Dysfunction",[1581,1598],"Testosterone",{"trials":1600,"activeCount":94},[],{"trials":1602,"activeCount":94},[],{"trials":1604,"activeCount":94},[],{"intervention":1598,"totalTrials":90,"cells":1606},{"EARLY_PHASE1":1607,"PHASE1":1609,"PHASE2":1611,"PHASE3":1617,"PHASE4":1619,"NA":1621},{"trials":1608,"activeCount":94},[],{"trials":1610,"activeCount":94},[],{"trials":1612,"activeCount":94},[1613],{"nctId":1590,"briefTitle":1591,"status":279,"phases":1614,"primaryCompletion":1593,"completion":493,"start":1594,"enrollment":1073,"conditions":1615,"interventions":1616},[84],[1596],[1581,1598],{"trials":1618,"activeCount":94},[],{"trials":1620,"activeCount":94},[],{"trials":1622,"activeCount":94},[],{"intervention":1624,"totalTrials":90,"cells":1625},"Uromune",{"EARLY_PHASE1":1626,"PHASE1":1628,"PHASE2":1630,"PHASE3":1643,"PHASE4":1645,"NA":1647},{"trials":1627,"activeCount":94},[],{"trials":1629,"activeCount":94},[],{"trials":1631,"activeCount":94},[1632],{"nctId":1633,"briefTitle":1634,"status":434,"phases":1635,"primaryCompletion":1636,"completion":1637,"start":1638,"enrollment":1639,"conditions":1640,"interventions":1642},"NCT04096820","Uromune in Treating Recurrent Urinary Tract Infections in Women",[84],"2022-10-31","2023-01-01","2019-09-06",67,[1641],"Recurrent Uti",[1624],{"trials":1644,"activeCount":94},[],{"trials":1646,"activeCount":94},[],{"trials":1648,"activeCount":94},[],{"intervention":1650,"totalTrials":90,"cells":1651},"solution contains 1 mg salbutamol plus 3% hypertonic saline",{"EARLY_PHASE1":1652,"PHASE1":1654,"PHASE2":1656,"PHASE3":1668,"PHASE4":1670,"NA":1672},{"trials":1653,"activeCount":94},[],{"trials":1655,"activeCount":94},[],{"trials":1657,"activeCount":94},[1658],{"nctId":1659,"briefTitle":1660,"status":279,"phases":1661,"primaryCompletion":1662,"completion":567,"start":523,"enrollment":1663,"conditions":1664,"interventions":1666},"NCT00677729","Hypertonic Saline to Reduce Hospital Admissions in Bronchiolitis",[84],"2009-04",81,[1665],"Viral Bronchiolitis",[1650,1667],"solution contains 1 mg salbutamol plus 0.9% saline",{"trials":1669,"activeCount":94},[],{"trials":1671,"activeCount":94},[],{"trials":1673,"activeCount":94},[],{"intervention":1667,"totalTrials":90,"cells":1675},{"EARLY_PHASE1":1676,"PHASE1":1678,"PHASE2":1680,"PHASE3":1686,"PHASE4":1688,"NA":1690},{"trials":1677,"activeCount":94},[],{"trials":1679,"activeCount":94},[],{"trials":1681,"activeCount":94},[1682],{"nctId":1659,"briefTitle":1660,"status":279,"phases":1683,"primaryCompletion":1662,"completion":567,"start":523,"enrollment":1663,"conditions":1684,"interventions":1685},[84],[1665],[1650,1667],{"trials":1687,"activeCount":94},[],{"trials":1689,"activeCount":94},[],{"trials":1691,"activeCount":94},[],{"intervention":1693,"totalTrials":90,"cells":1694},"Inhaled Carbon Monoxide",{"EARLY_PHASE1":1695,"PHASE1":1697,"PHASE2":1699,"PHASE3":1711,"PHASE4":1713,"NA":1715},{"trials":1696,"activeCount":94},[],{"trials":1698,"activeCount":94},[],{"trials":1700,"activeCount":94},[1701],{"nctId":1702,"briefTitle":1703,"status":434,"phases":1704,"primaryCompletion":1705,"completion":1705,"start":1706,"enrollment":243,"conditions":1707,"interventions":1709},"NCT01050712","Study of Inhaling Carbon Monoxide to Treat Patients With Intestinal Paralysis After Colon Surgery.",[84],"2013-09","2011-04",[1708],"Ileus",[1693,1710],"Synthetic Air",{"trials":1712,"activeCount":94},[],{"trials":1714,"activeCount":94},[],{"trials":1716,"activeCount":94},[],{"intervention":1710,"totalTrials":90,"cells":1718},{"EARLY_PHASE1":1719,"PHASE1":1721,"PHASE2":1723,"PHASE3":1729,"PHASE4":1731,"NA":1733},{"trials":1720,"activeCount":94},[],{"trials":1722,"activeCount":94},[],{"trials":1724,"activeCount":94},[1725],{"nctId":1702,"briefTitle":1703,"status":434,"phases":1726,"primaryCompletion":1705,"completion":1705,"start":1706,"enrollment":243,"conditions":1727,"interventions":1728},[84],[1708],[1693,1710],{"trials":1730,"activeCount":94},[],{"trials":1732,"activeCount":94},[],{"trials":1734,"activeCount":94},[],{"intervention":1736,"totalTrials":90,"cells":1737},"Amino Acid",{"EARLY_PHASE1":1738,"PHASE1":1740,"PHASE2":1742,"PHASE3":1752,"PHASE4":1754,"NA":1756},{"trials":1739,"activeCount":94},[],{"trials":1741,"activeCount":94},[],{"trials":1743,"activeCount":94},[1744],{"nctId":1745,"briefTitle":1746,"status":554,"phases":1747,"completion":533,"start":723,"enrollment":94,"conditions":1748,"interventions":1751},"NCT00313807","Study of Intravenous Amino Acid Infusion to Prevent Contrast Dye Mediated Renal Damage",[84],[1749,1750],"Contrast Nephropathy","Renal Failure",[1736],{"trials":1753,"activeCount":94},[],{"trials":1755,"activeCount":94},[],{"trials":1757,"activeCount":94},[],{"intervention":1759,"totalTrials":90,"cells":1760},"250 ppm carbon monoxide",{"EARLY_PHASE1":1761,"PHASE1":1763,"PHASE2":1773,"PHASE3":1775,"PHASE4":1777,"NA":1779},{"trials":1762,"activeCount":94},[],{"trials":1764,"activeCount":94},[1765],{"nctId":1766,"briefTitle":1767,"status":434,"phases":1768,"primaryCompletion":770,"completion":1769,"start":1770,"enrollment":108,"conditions":1771,"interventions":1772},"NCT01050933","Safety Study of Inhaling Carbon Monoxide in Healthy Volunteers",[83],"2011-10","2010-09",[22],[1759],{"trials":1774,"activeCount":94},[],{"trials":1776,"activeCount":94},[],{"trials":1778,"activeCount":94},[],{"trials":1780,"activeCount":94},[],{"intervention":1782,"totalTrials":90,"cells":1783},"Wellbutrin XL",{"EARLY_PHASE1":1784,"PHASE1":1786,"PHASE2":1798,"PHASE3":1800,"PHASE4":1802,"NA":1804},{"trials":1785,"activeCount":94},[],{"trials":1787,"activeCount":94},[1788],{"nctId":1789,"briefTitle":1790,"status":279,"phases":1791,"primaryCompletion":1792,"completion":1793,"start":1794,"enrollment":10,"conditions":1795,"interventions":1797},"NCT00616915","Does Sleep Quality Change After Switch From Wellbutrin SR to Wellbutrin XL in Patients With Major Depressive Disorder?",[83],"2009-01","2010-01","2007-01",[1796],"Mood Disorder",[1782],{"trials":1799,"activeCount":94},[],{"trials":1801,"activeCount":94},[],{"trials":1803,"activeCount":94},[],{"trials":1805,"activeCount":94},[],{"intervention":1807,"totalTrials":90,"cells":1808},"Botox",{"EARLY_PHASE1":1809,"PHASE1":1811,"PHASE2":1824,"PHASE3":1826,"PHASE4":1828,"NA":1830},{"trials":1810,"activeCount":94},[],{"trials":1812,"activeCount":94},[1813],{"nctId":1814,"briefTitle":1815,"status":434,"phases":1816,"primaryCompletion":1817,"completion":1818,"start":1819,"enrollment":23,"conditions":1820,"interventions":1823},"NCT00529386","Botox for Chronic Prostatitis\u002FChronic Pelvic Pain Syndrome (CP\u002FCPPS)",[83],"2009-09","2009-12","2006-01",[1821,1822],"Prostatitis","Chronic Pain Syndrome",[1807],{"trials":1825,"activeCount":94},[],{"trials":1827,"activeCount":94},[],{"trials":1829,"activeCount":94},[],{"trials":1831,"activeCount":94},[],{"intervention":622,"totalTrials":243,"cells":1833},{"EARLY_PHASE1":1834,"PHASE1":1836,"PHASE2":1838,"PHASE3":1840,"PHASE4":1842,"NA":1848},{"trials":1835,"activeCount":94},[],{"trials":1837,"activeCount":94},[],{"trials":1839,"activeCount":94},[],{"trials":1841,"activeCount":94},[],{"trials":1843,"activeCount":94},[1844],{"nctId":613,"briefTitle":614,"status":279,"phases":1845,"primaryCompletion":616,"completion":616,"start":617,"enrollment":618,"conditions":1846,"interventions":1847},[86],[620],[600,622],{"trials":1849,"activeCount":94},[1850,1863],{"nctId":1851,"briefTitle":1852,"status":279,"phases":1853,"primaryCompletion":1854,"completion":1855,"start":1794,"enrollment":1073,"conditions":1856,"interventions":1859},"NCT00485108","Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty",[87],"2009-06","2014-12",[1857,1858],"Primary Open Angle Glaucoma","Pseudoexfoliation Glaucoma",[1860,1861,1862],"prednisolone 1%","ketorolac 0.5%","Artificial Tears",{"nctId":1864,"briefTitle":1865,"status":279,"phases":1866,"primaryCompletion":1072,"completion":1072,"start":1867,"enrollment":495,"conditions":1868,"interventions":1869},"NCT00974753","Prophylactic Ketorolac Post Epiretinal Membrane Surgery",[87],"2010-03",[620],[622],{"intervention":1375,"totalTrials":446,"cells":1871},{"EARLY_PHASE1":1872,"PHASE1":1874,"PHASE2":1876,"PHASE3":1878,"PHASE4":1884,"NA":1886},{"trials":1873,"activeCount":94},[],{"trials":1875,"activeCount":94},[],{"trials":1877,"activeCount":94},[],{"trials":1879,"activeCount":94},[1880],{"nctId":1366,"briefTitle":1367,"status":434,"phases":1881,"primaryCompletion":1369,"completion":1370,"start":911,"enrollment":1371,"conditions":1882,"interventions":1883},[85],[1373],[1375,1355],{"trials":1885,"activeCount":94},[],{"trials":1887,"activeCount":94},[1888],{"nctId":1889,"briefTitle":1890,"status":254,"phases":1891,"primaryCompletion":1892,"completion":1892,"start":1008,"enrollment":1893,"conditions":1894,"interventions":1897},"NCT01450566","Intraureteral Lidocaine for Post-Ureteroscopy Pain",[87],"2013-12",48,[1895,1896],"Ureteral Calculi","Renal Calculi",[1898,1899],"Lidocaine","Saline",{"intervention":1901,"totalTrials":446,"cells":1902},"Escitalopram",{"EARLY_PHASE1":1903,"PHASE1":1905,"PHASE2":1914,"PHASE3":1916,"PHASE4":1918,"NA":1920},{"trials":1904,"activeCount":94},[],{"trials":1906,"activeCount":94},[1907],{"nctId":1908,"briefTitle":1909,"status":434,"phases":1910,"primaryCompletion":1793,"completion":1793,"start":862,"enrollment":90,"conditions":1911,"interventions":1913},"NCT00272025","Treatment Resistant Bipolar Depression",[83],[1912],"Bipolar Depression",[1901],{"trials":1915,"activeCount":94},[],{"trials":1917,"activeCount":94},[],{"trials":1919,"activeCount":94},[],{"trials":1921,"activeCount":94},[1922],{"nctId":1923,"briefTitle":1924,"status":279,"phases":1925,"primaryCompletion":1594,"completion":1926,"start":724,"enrollment":20,"conditions":1927,"interventions":1928},"NCT00150527","Specific Effects of Escitalopram on Neuroendocrine Response",[],"2007-12",[22],[1929,1901,1930],"Citalopram","Dexamethasone",{"intervention":1932,"totalTrials":90,"cells":1933},"Diuretic-Based or Non-Diuretic Based Hypertension Therapy",{"EARLY_PHASE1":1934,"PHASE1":1936,"PHASE2":1938,"PHASE3":1940,"PHASE4":1942,"NA":1944},{"trials":1935,"activeCount":94},[],{"trials":1937,"activeCount":94},[],{"trials":1939,"activeCount":94},[],{"trials":1941,"activeCount":94},[],{"trials":1943,"activeCount":94},[],{"trials":1945,"activeCount":94},[1946],{"nctId":1947,"briefTitle":1948,"status":279,"phases":1949,"primaryCompletion":1594,"completion":1950,"start":1951,"enrollment":1371,"conditions":1952,"interventions":1953},"NCT00229242","Comparison of Diuretic-based With Non-diuretic Based Hypertension Therapy Using Echocardiographic Measures",[87],"2007-03","2003-11",[29],[1932],{"intervention":1955,"totalTrials":90,"cells":1956},"Sennosides",{"EARLY_PHASE1":1957,"PHASE1":1959,"PHASE2":1961,"PHASE3":1963,"PHASE4":1965,"NA":1967},{"trials":1958,"activeCount":94},[],{"trials":1960,"activeCount":94},[],{"trials":1962,"activeCount":94},[],{"trials":1964,"activeCount":94},[],{"trials":1966,"activeCount":94},[],{"trials":1968,"activeCount":94},[1969],{"nctId":1970,"briefTitle":1971,"status":279,"phases":1972,"primaryCompletion":1973,"completion":1973,"start":1974,"enrollment":1975,"conditions":1976,"interventions":1978},"NCT02618564","The Use of Sennosides With Pico Salax in Bowel Preparation for Colonoscopy: a Study of Optimal Dose and Timing",[87],"2017-08","2016-01",100,[1977],"Colonoscopy Preparation Outcome",[1955],{"intervention":1860,"totalTrials":90,"cells":1980},{"EARLY_PHASE1":1981,"PHASE1":1983,"PHASE2":1985,"PHASE3":1987,"PHASE4":1989,"NA":1991},{"trials":1982,"activeCount":94},[],{"trials":1984,"activeCount":94},[],{"trials":1986,"activeCount":94},[],{"trials":1988,"activeCount":94},[],{"trials":1990,"activeCount":94},[],{"trials":1992,"activeCount":94},[1993],{"nctId":1851,"briefTitle":1852,"status":279,"phases":1994,"primaryCompletion":1854,"completion":1855,"start":1794,"enrollment":1073,"conditions":1995,"interventions":1996},[87],[1857,1858],[1860,1861,1862],{"intervention":1862,"totalTrials":90,"cells":1998},{"EARLY_PHASE1":1999,"PHASE1":2001,"PHASE2":2003,"PHASE3":2005,"PHASE4":2007,"NA":2009},{"trials":2000,"activeCount":94},[],{"trials":2002,"activeCount":94},[],{"trials":2004,"activeCount":94},[],{"trials":2006,"activeCount":94},[],{"trials":2008,"activeCount":94},[],{"trials":2010,"activeCount":94},[2011],{"nctId":1851,"briefTitle":1852,"status":279,"phases":2012,"primaryCompletion":1854,"completion":1855,"start":1794,"enrollment":1073,"conditions":2013,"interventions":2014},[87],[1857,1858],[1860,1861,1862],{"intervention":2016,"totalTrials":90,"cells":2017},"gatifloxacin ophthalmic",{"EARLY_PHASE1":2018,"PHASE1":2020,"PHASE2":2022,"PHASE3":2024,"PHASE4":2026,"NA":2028},{"trials":2019,"activeCount":94},[],{"trials":2021,"activeCount":94},[],{"trials":2023,"activeCount":94},[],{"trials":2025,"activeCount":94},[],{"trials":2027,"activeCount":94},[],{"trials":2029,"activeCount":94},[2030],{"nctId":2031,"briefTitle":2032,"status":554,"phases":2033,"primaryCompletion":481,"completion":481,"start":2034,"enrollment":94,"conditions":2035,"interventions":2037},"NCT00335231","Preoperative Topical Gatifloxacin on Anterior Chamber Cultures After Cataract Surgery",[87],"2006-06",[2036],"Endophthalmitis",[2016],{"intervention":2039,"totalTrials":90,"cells":2040},"methylene blue",{"EARLY_PHASE1":2041,"PHASE1":2043,"PHASE2":2045,"PHASE3":2047,"PHASE4":2049,"NA":2051},{"trials":2042,"activeCount":94},[],{"trials":2044,"activeCount":94},[],{"trials":2046,"activeCount":94},[],{"trials":2048,"activeCount":94},[],{"trials":2050,"activeCount":94},[],{"trials":2052,"activeCount":94},[2053],{"nctId":2054,"briefTitle":2055,"status":554,"phases":2056,"start":2057,"enrollment":94,"conditions":2058,"interventions":2060},"NCT00486174","Methylene Blue in Sepsis: A Randomized Controlled Trial",[87],"2007-06",[2059],"Sepsis",[2039],{"intervention":2062,"totalTrials":90,"cells":2063},"Citric acid",{"EARLY_PHASE1":2064,"PHASE1":2066,"PHASE2":2068,"PHASE3":2070,"PHASE4":2072,"NA":2074},{"trials":2065,"activeCount":94},[],{"trials":2067,"activeCount":94},[],{"trials":2069,"activeCount":94},[],{"trials":2071,"activeCount":94},[],{"trials":2073,"activeCount":94},[],{"trials":2075,"activeCount":94},[2076],{"nctId":2077,"briefTitle":2078,"status":279,"phases":2079,"primaryCompletion":2080,"completion":2080,"start":2081,"enrollment":2082,"conditions":2083,"interventions":2085},"NCT03999203","A Cross-sectional Study to Measure Cough in Severe Asthma",[87],"2019-12-30","2017-10-04",61,[483,2084],"Cough",[2062],{"intervention":2087,"totalTrials":90,"cells":2088},"Lipitor 20 mg",{"EARLY_PHASE1":2089,"PHASE1":2091,"PHASE2":2093,"PHASE3":2095,"PHASE4":2097,"NA":2099},{"trials":2090,"activeCount":94},[],{"trials":2092,"activeCount":94},[],{"trials":2094,"activeCount":94},[],{"trials":2096,"activeCount":94},[],{"trials":2098,"activeCount":94},[],{"trials":2100,"activeCount":94},[2101],{"nctId":2102,"briefTitle":2103,"status":279,"phases":2104,"primaryCompletion":2105,"completion":2105,"start":2106,"enrollment":2107,"conditions":2108,"interventions":2110},"NCT00299884","Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy",[],"2006-07","2005-01",45,[497,2109],"Vascular Disease",[2087,2111],"Combination Ezetrol 10 mg and Lipidil Supra 160 mg",{"intervention":2111,"totalTrials":90,"cells":2113},{"EARLY_PHASE1":2114,"PHASE1":2116,"PHASE2":2118,"PHASE3":2120,"PHASE4":2122,"NA":2124},{"trials":2115,"activeCount":94},[],{"trials":2117,"activeCount":94},[],{"trials":2119,"activeCount":94},[],{"trials":2121,"activeCount":94},[],{"trials":2123,"activeCount":94},[],{"trials":2125,"activeCount":94},[2126],{"nctId":2102,"briefTitle":2103,"status":279,"phases":2127,"primaryCompletion":2105,"completion":2105,"start":2106,"enrollment":2107,"conditions":2128,"interventions":2129},[],[497,2109],[2087,2111],{"intervention":2131,"totalTrials":90,"cells":2132},"Low dose bupivicaine in spinal anesthetic",{"EARLY_PHASE1":2133,"PHASE1":2135,"PHASE2":2137,"PHASE3":2139,"PHASE4":2141,"NA":2143},{"trials":2134,"activeCount":94},[],{"trials":2136,"activeCount":94},[],{"trials":2138,"activeCount":94},[],{"trials":2140,"activeCount":94},[],{"trials":2142,"activeCount":94},[],{"trials":2144,"activeCount":94},[2145],{"nctId":2146,"briefTitle":2147,"status":279,"phases":2148,"primaryCompletion":886,"completion":886,"start":1157,"enrollment":2149,"conditions":2150,"interventions":2153},"NCT00537472","Low Dose Spinal Bupivacaine for Total Knee Replacement and Recovery Room Wait Time",[87],140,[2151,2152],"Spinal Anesthesia","Total Knee Arthroplasty",[2131,2154],"Standard dose bupivacaine in spinal anesthetic",{"intervention":2154,"totalTrials":90,"cells":2156},{"EARLY_PHASE1":2157,"PHASE1":2159,"PHASE2":2161,"PHASE3":2163,"PHASE4":2165,"NA":2167},{"trials":2158,"activeCount":94},[],{"trials":2160,"activeCount":94},[],{"trials":2162,"activeCount":94},[],{"trials":2164,"activeCount":94},[],{"trials":2166,"activeCount":94},[],{"trials":2168,"activeCount":94},[2169],{"nctId":2146,"briefTitle":2147,"status":279,"phases":2170,"primaryCompletion":886,"completion":886,"start":1157,"enrollment":2149,"conditions":2171,"interventions":2172},[87],[2151,2152],[2131,2154],{"intervention":2174,"totalTrials":90,"cells":2175},"Seroquel",{"EARLY_PHASE1":2176,"PHASE1":2178,"PHASE2":2180,"PHASE3":2182,"PHASE4":2184,"NA":2186},{"trials":2177,"activeCount":94},[],{"trials":2179,"activeCount":94},[],{"trials":2181,"activeCount":94},[],{"trials":2183,"activeCount":94},[],{"trials":2185,"activeCount":94},[],{"trials":2187,"activeCount":94},[2188],{"nctId":2189,"briefTitle":2190,"status":279,"phases":2191,"primaryCompletion":1792,"completion":1792,"start":2192,"enrollment":569,"conditions":2193,"interventions":2194},"NCT00616889","Effect of Quetiapine on Sleep Architecture in Bipolar Depression and Major Depressive Disorder",[],"2006-05",[1160],[2174],{"intervention":2196,"totalTrials":90,"cells":2197},"ketorolac tromethamine 0.5%",{"EARLY_PHASE1":2198,"PHASE1":2200,"PHASE2":2202,"PHASE3":2204,"PHASE4":2206,"NA":2208},{"trials":2199,"activeCount":94},[],{"trials":2201,"activeCount":94},[],{"trials":2203,"activeCount":94},[],{"trials":2205,"activeCount":94},[],{"trials":2207,"activeCount":94},[],{"trials":2209,"activeCount":94},[2210],{"nctId":2211,"briefTitle":2212,"status":279,"phases":2213,"primaryCompletion":1134,"completion":1134,"start":2034,"enrollment":594,"conditions":2214,"interventions":2216},"NCT00335439","Effect of Prophylactic Ketorolac on CME After Cataract Surgery",[87],[2215],"Macular Edema, Cystoid",[2196],{"intervention":2218,"totalTrials":90,"cells":2219},"Sodium-glucose cotransporter 2 inhibitor",{"EARLY_PHASE1":2220,"PHASE1":2222,"PHASE2":2224,"PHASE3":2226,"PHASE4":2228,"NA":2230},{"trials":2221,"activeCount":94},[],{"trials":2223,"activeCount":94},[],{"trials":2225,"activeCount":94},[],{"trials":2227,"activeCount":94},[],{"trials":2229,"activeCount":94},[],{"trials":2231,"activeCount":94},[2232],{"nctId":2233,"briefTitle":2234,"status":254,"phases":2235,"primaryCompletion":2236,"completion":2237,"start":2238,"enrollment":2239,"conditions":2240,"interventions":2242},"NCT06140251","Investigation of Biomarker Response to SGLT2 Inhibition in Heart Failure",[],"2024-09-01","2025-05-01","2023-08-21",68,[2241],"Heart Failure",[2218],{"intervention":2244,"totalTrials":90,"cells":2245},"\"synthetic stool\" or pure cultures of probiotic intestinal bacteria",{"EARLY_PHASE1":2246,"PHASE1":2248,"PHASE2":2250,"PHASE3":2252,"PHASE4":2254,"NA":2256},{"trials":2247,"activeCount":94},[],{"trials":2249,"activeCount":94},[],{"trials":2251,"activeCount":94},[],{"trials":2253,"activeCount":94},[],{"trials":2255,"activeCount":94},[],{"trials":2257,"activeCount":94},[2258],{"nctId":2259,"briefTitle":2260,"status":434,"phases":2261,"primaryCompletion":2262,"completion":2263,"start":1793,"enrollment":379,"conditions":2264,"interventions":2266},"NCT01372943","Harnessing the Healthy Gut Microbiota to Cure Patients With Recurrent C. Difficile Infection",[87],"2017-01","2018-08-31",[2265],"Clostridium Difficile Infection",[2244],{"intervention":2268,"totalTrials":90,"cells":2269},"Anesthetic Dilating Gel",{"EARLY_PHASE1":2270,"PHASE1":2272,"PHASE2":2274,"PHASE3":2276,"PHASE4":2278,"NA":2280},{"trials":2271,"activeCount":94},[],{"trials":2273,"activeCount":94},[],{"trials":2275,"activeCount":94},[],{"trials":2277,"activeCount":94},[],{"trials":2279,"activeCount":94},[],{"trials":2281,"activeCount":94},[2282],{"nctId":2283,"briefTitle":2284,"status":279,"phases":2285,"completion":1134,"start":938,"enrollment":10,"conditions":2286,"interventions":2288},"NCT00335400","Anesthetic and Dilating Gel for Cataract Surgery",[87],[2287],"Cataract",[2268],{"intervention":1929,"totalTrials":90,"cells":2290},{"EARLY_PHASE1":2291,"PHASE1":2293,"PHASE2":2295,"PHASE3":2297,"PHASE4":2299,"NA":2301},{"trials":2292,"activeCount":94},[],{"trials":2294,"activeCount":94},[],{"trials":2296,"activeCount":94},[],{"trials":2298,"activeCount":94},[],{"trials":2300,"activeCount":94},[],{"trials":2302,"activeCount":94},[2303],{"nctId":1923,"briefTitle":1924,"status":279,"phases":2304,"primaryCompletion":1594,"completion":1926,"start":724,"enrollment":20,"conditions":2305,"interventions":2306},[],[22],[1929,1901,1930],{"intervention":1930,"totalTrials":90,"cells":2308},{"EARLY_PHASE1":2309,"PHASE1":2311,"PHASE2":2313,"PHASE3":2315,"PHASE4":2317,"NA":2319},{"trials":2310,"activeCount":94},[],{"trials":2312,"activeCount":94},[],{"trials":2314,"activeCount":94},[],{"trials":2316,"activeCount":94},[],{"trials":2318,"activeCount":94},[],{"trials":2320,"activeCount":94},[2321],{"nctId":1923,"briefTitle":1924,"status":279,"phases":2322,"primaryCompletion":1594,"completion":1926,"start":724,"enrollment":20,"conditions":2323,"interventions":2324},[],[22],[1929,1901,1930],{"intervention":2326,"totalTrials":90,"cells":2327},"intravitreal ranibizumab",{"EARLY_PHASE1":2328,"PHASE1":2330,"PHASE2":2332,"PHASE3":2334,"PHASE4":2336,"NA":2338},{"trials":2329,"activeCount":94},[],{"trials":2331,"activeCount":94},[],{"trials":2333,"activeCount":94},[],{"trials":2335,"activeCount":94},[],{"trials":2337,"activeCount":94},[],{"trials":2339,"activeCount":94},[2340],{"nctId":2341,"briefTitle":2342,"status":279,"phases":2343,"primaryCompletion":2344,"completion":1396,"start":2345,"enrollment":2346,"conditions":2347,"interventions":2349},"NCT01238393","Treatment of Epiretinal Membranes With Ranibizumab",[87],"2011-11","2010-11",11,[2348],"Epiretinal Membrane",[2326],{"intervention":2351,"totalTrials":90,"cells":2352},"fentanyl",{"EARLY_PHASE1":2353,"PHASE1":2355,"PHASE2":2357,"PHASE3":2359,"PHASE4":2361,"NA":2363},{"trials":2354,"activeCount":94},[],{"trials":2356,"activeCount":94},[],{"trials":2358,"activeCount":94},[],{"trials":2360,"activeCount":94},[],{"trials":2362,"activeCount":94},[],{"trials":2364,"activeCount":94},[2365],{"nctId":2366,"briefTitle":2367,"status":279,"phases":2368,"primaryCompletion":2369,"completion":2369,"start":1793,"enrollment":258,"conditions":2370,"interventions":2371},"NCT00974220","Effect of Inhaled Fentanyl on Dyspnea and Exercise Tolerance in Chronic Obstructive Pulmonary Disease (COPD)",[87],"2010-12",[25],[2351,2372],"normal saline",{"intervention":2372,"totalTrials":90,"cells":2374},{"EARLY_PHASE1":2375,"PHASE1":2377,"PHASE2":2379,"PHASE3":2381,"PHASE4":2383,"NA":2385},{"trials":2376,"activeCount":94},[],{"trials":2378,"activeCount":94},[],{"trials":2380,"activeCount":94},[],{"trials":2382,"activeCount":94},[],{"trials":2384,"activeCount":94},[],{"trials":2386,"activeCount":94},[2387],{"nctId":2366,"briefTitle":2367,"status":279,"phases":2388,"primaryCompletion":2369,"completion":2369,"start":1793,"enrollment":258,"conditions":2389,"interventions":2390},[87],[25],[2351,2372],{"intervention":1899,"totalTrials":90,"cells":2392},{"EARLY_PHASE1":2393,"PHASE1":2395,"PHASE2":2397,"PHASE3":2399,"PHASE4":2401,"NA":2403},{"trials":2394,"activeCount":94},[],{"trials":2396,"activeCount":94},[],{"trials":2398,"activeCount":94},[],{"trials":2400,"activeCount":94},[],{"trials":2402,"activeCount":94},[],{"trials":2404,"activeCount":94},[2405],{"nctId":1889,"briefTitle":1890,"status":254,"phases":2406,"primaryCompletion":1892,"completion":1892,"start":1008,"enrollment":1893,"conditions":2407,"interventions":2408},[87],[1895,1896],[1898,1899],{"intervention":2410,"totalTrials":90,"cells":2411},"fluticasone\u002Fsalmeterol combination",{"EARLY_PHASE1":2412,"PHASE1":2414,"PHASE2":2416,"PHASE3":2418,"PHASE4":2420,"NA":2422},{"trials":2413,"activeCount":94},[],{"trials":2415,"activeCount":94},[],{"trials":2417,"activeCount":94},[],{"trials":2419,"activeCount":94},[],{"trials":2421,"activeCount":94},[],{"trials":2423,"activeCount":94},[2424],{"nctId":2425,"briefTitle":2426,"status":279,"phases":2427,"primaryCompletion":1867,"completion":2428,"start":1926,"enrollment":495,"conditions":2429,"interventions":2430},"NCT00559312","The Effect of Fluticasone\u002FSalmeterol Combination on Exertional Breathlessness in Patients With Mild COPD",[87],"2010-04",[749],[2410]]